Humana's CenterWell Partners with Mark Cuban Cost Plus Drugs to Reduce Employer Prescription Costs

Humana’s CenterWell Pharmacy and Mark Cuban Cost Plus Drugs have announced a strategic partnership aimed at creating comprehensive solutions for employer prescription management. The collaboration, unveiled on Monday, is designed to enhance operational efficiency and reduce drug costs for employers and their employees.

Why it Matters

The partnership between Humana's CenterWell Pharmacy and Mark Cuban Cost Plus Drugs is significant in the ongoing effort to address rising healthcare costs, particularly in the realm of prescription drugs. Employers are increasingly looking for ways to manage the financial burden of providing health benefits, and this collaboration offers a promising solution by leveraging innovative technology and transparent pricing models.

Key Details

Under the new arrangement, CenterWell Pharmacy will become an official pharmacy partner of Cost Plus Drugs. The Humana business unit will integrate Cost Plus Drugs' SwiftyRx software platform into its operations to streamline medication order intake. This integration is expected to enhance patient onboarding, automate benefit checks, and reduce the overall costs associated with filling prescriptions.

Mark Cuban, co-founder of Cost Plus Drugs, emphasized the importance of accessibility and affordability in healthcare: "Everyone should be able to get safe, affordable medication. This collaboration gives Cost Plus Drugs the chance to support more consumers. We’re working with CenterWell Pharmacy because we trust the team and like what they’re doing in trying to improve prescription affordability."

Operational Efficiencies

The combination of SwiftyRx's capabilities and CenterWell Pharmacy's distribution infrastructure is expected to drive several operational efficiencies:

• Easier Patient Onboarding: The software will simplify the process for patients to start their medication regimens.
• Automated Benefit Checks: SwiftyRx can automatically verify insurance coverage, reducing administrative burdens.
• Reduced Costs: By adopting a pass-through drug pricing model, the partnership aims to lower the costs of prescription drugs for employers and employees.

Historical Context

The collaboration between Humana and Cost Plus Drugs has been in the works since December 2025, when Cuban and Humana CEO Jim Rechtin first hinted at their discussions. At that time, Cuban highlighted the potential savings from direct-to-employer programs that bypass traditional pharmacy benefit manager (PBM) models. "Widespread adoption of these programs could save members billions and billions of dollars across consumers," he stated.

Rechtin echoed this sentiment, noting that Humana's CenterWell Pharmacy was built with the goal of simplifying access to medications for its members. In 2025, CenterWell generated $22.5 billion in revenue, with the pharmacy division alone contributing nearly $13 billion (up from $11.6 billion in 2024). However, operating costs also increased due to higher volume within its specialty pharmacy segment.

The Opportunity

This partnership presents a unique opportunity for both companies to expand their reach and impact. For Cost Plus Drugs, the collaboration with a major healthcare provider like Humana can significantly enhance its ability to scale its cost-saving initiatives. For Humana, it offers a chance to strengthen its offerings in the employer health market and further differentiate itself from competitors.

Key Risks

While the partnership holds significant promise, several risks must be considered:

• Implementation Challenges: Integrating new software and processes can be complex and may face initial resistance from users.
• Market Competition: Other healthcare providers and PBMs are also exploring similar cost-reduction strategies, which could limit the market share gained by this partnership.
• Regulatory Hurdles: The healthcare industry is heavily regulated, and any new approach must navigate a complex landscape of compliance requirements.

Conclusion

The partnership between Humana's CenterWell Pharmacy and Mark Cuban Cost Plus Drugs represents a significant step towards addressing the pressing issue of high prescription drug costs. By combining innovative technology with transparent pricing models, this collaboration has the potential to deliver meaningful savings for employers and their employees while enhancing overall healthcare accessibility.